Globex Mining Enterprises has expanded its Gem Hills rare earth elements (REE) project in Nevada to 20 claims, uncovering a potentially new class of high-grade, hydrothermal ion-adsorption REE deposits. The project features significant heavy rare earth element enrichment, low radiation levels, and environmentally favorable mineralogy, suggesting lower-cost and safer extraction methods. Advanced synchrotron X-ray analysis confirmed the REE are mainly adsorbed to clay minerals, offering a unique processing advantage. Globex aims to advance exploration with potential federal support and strategic partnerships to secure a domestic supply of critical minerals.
Globex Mining Enterprises' Gem Hills project expansion offers context for readers interested in rare earth elements. For readers following the Basic Materials sector, here is Pluang's market snapshot as of Nov 02, 2026 19:41 WIB: out of 83 priced US stocks, 64 rose and 10 fell. Notable movers include AUGO at USD 67.77 with a 2.34% increase and AU at USD 81.52 with a 2.21% increase.
Thailand's textile market is projected to grow from USD 4.97 billion in 2026 to USD 5.39 billion by 2032, at a CAGR of 1.31%. Growth is fueled by domestic fiber production, machinery upgrades, and rising demand for faster garment replenishment, espec...
A SEON survey of 2,026 U.S. adults reveals that while 68% use AI agents weekly for personal tasks, half are uncomfortable letting AI handle credit card purchases. Only 15% would share financial info with AI, and 43% lack confidence in spotting fraudu...
Callan JMB has received and will install a QuickStrip™ oral thin-film production line from Rapid Dose Therapeutics at its Texas facility, marking a key step in expanding its domestic pharmaceutical manufacturing. This new capability aims to produce f...
Known, a company developing accountability infrastructure for autonomous AI, announced that Edna Conway, former senior security executive at Microsoft and Cisco, has joined its Advisory Council. Conway brings extensive experience in cybersecurity and...
Radiopharm Theranostics announced progress in its oncology radiopharmaceutical pipeline, including preparing for a pivotal Phase 3 imaging trial of RAD101 for recurrent brain metastases after a successful FDA End-of-Phase 2 meeting. The company also ...
